Product NDC: | 0093-2130 |
Proprietary Name: | Nitrofurantoin Macrocrystals |
Non Proprietary Name: | Nitrofurantoin Macrocrystals |
Active Ingredient(s): | 50 mg/1 & nbsp; Nitrofurantoin Macrocrystals |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-2130 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073671 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070308 |
Package NDC: | 0093-2130-10 |
Package Description: | 1000 CAPSULE in 1 BOTTLE (0093-2130-10) |
NDC Code | 0093-2130-10 |
Proprietary Name | Nitrofurantoin Macrocrystals |
Package Description | 1000 CAPSULE in 1 BOTTLE (0093-2130-10) |
Product NDC | 0093-2130 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Nitrofurantoin Macrocrystals |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20070308 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | NITROFURANTOIN |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Nitrofuran Antibacterial [EPC],Nitrofurans [Chemical/Ingredient] |